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Predictive in vitro methods to investigate drug metabolism in the human intestine using 
intact tissue are of high importance. Therefore, we studied the metabolic activity of human 
small intestinal and colon slices and compared it with the metabolic activity of the same 
human intestinal segments using the Ussing chamber technique. The metabolic activity was 
evaluated using substrates to both phase I and phase II reactions: testosterone, 7-
hydroxycoumarin (7HC) and a cocktail of CYP substrates (midazolam, diclofenac, coumarin 
and bufuralol). In slices of human proximal jejunum, the metabolic activity of several CYP 
mediated and conjugation reactions remained constant up to 4 h of incubation. In the colon 
slices, conjugation rates were virtually equal to those in small intestine; while CYP mediated 
conversions occurred much slower. In both organs, morphological evaluation and ATP 
content implied tissue integrity within this period. CYP conversions using the Ussing 
chamber technique showed that the metabolic rate (sum of metabolites measured in apical, 
basolateral and tissue compartments) was constant up to 3 h. For 7HC conjugations, the 
metabolic rate remained constant up to 4 h. The distribution of the metabolites in the 
compartments differed between the substrates. Overall, metabolic rates were surprisingly 
similar in both techniques and appear similar to or even higher than in liver. In conclusion, 
this study shows that both human intestinal precision-cut slices as well as Ussing chamber 






















List of non-standard abbreviations: 
ACN: acetonitril, DMSO: Dimethylsulfoxide, KBR: Krebs-Bicarbonate Ringer solution, MeOH: Methanol, 
PD: Potential differences, R: Resistance, SCC: Short circuit current, TFA: Tri Fluoro Acetic acid, TOH: 
hydroxytestosterone, TT: Testosterone, WME: Williams Medium E, 7HC: 7-hydroxycoumarin, 7HC-
GLUC: 7-hydroxycoumarin glucuronide, 7HC-SULF: 7-hydroxycoumarin sulphate  
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Introduction 
Although the liver has long been thought to play the major role in drug metabolism, the 
metabolic capacity of the intestine has been increasingly recognized [1,2].  
In the seventies of the 20
th
 century, intestinal metabolism was already reported [3]. 
Nonetheless, until recently the clinical significance of intestinal drug metabolism remained 
under debate [4,5]. Although basic knowledge concerning human intestinal drug enzyme 
and transporters expression has been collected over the last decade [6,7], the ultimate proof 
for their significance has been given by in vivo studies. For several compounds, such as 
cyclosporine, verapamil and midazolam, in vivo studies have shown significant first-pass 
metabolism by the intestinal wall [1,2,8]. The significance of the intestine in determining the 
faith of drugs within the body is not only expressed by its high capacity to metabolize drugs, 
but also by its sensitivity to induction and inhibition of drug metabolizing enzymes [9], in 
addition to the interplay between transporters and metabolic activity [10-12]. 
The challenge in studying human intestinal metabolism nowadays is to develop in vitro 
systems in which intact cells remain functioning, since quantitative in vivo studies are difficult 
to perform. Subcellular human intestinal fractions, such as microsomal preparations and S-9 
fractions, have been used up to 30 minutes of incubation [13]. However, in addition to their 
limited lifespan, they lack the operable cell-membrane transporters and are often incubated 
with non-physiological concentrations of co-factors. Furthermore, Caco-2 cells have been 
proven to be useful for absorption studies [14,15]. However, interlaboratory reproducibility of 
Caco-2 cells is problematic and they are lacking normal levels of important metabolic 
enzymes such as CYP3A4 [16].  
 
Until now, several intact cell systems exist to study intestinal metabolism. Recently, the 
precision-cut slice technique was applied to rat intestinal tissue and these studies showed 
that intestinal precision-cut slices are superior to so-called intestinal tissue biopsy punches 
[17]. In addition, they exhibit drug metabolism at a constant rate for at least 3 h of incubation 
[18]. With the very efficient and rapid slice technique, many slices can be produced from a 
small tissue sample maintaining the cells in their physiological context with respect to 
metabolic enzymes, membrane transporters and co-factors. The applicability of this system 
for human tissue, however, has not been validated to date. The Ussing chamber technique, 
in which a small piece of mucosal tissue is mounted such that mucosal and serosal side are 
separately exposed to incubation medium, has been proven to be useful in absorption 
studies [19] and successfully predicts human intestinal permeability in vivo for several 
compounds [20]. However, to our knowledge, studies using Ussing chamber preparations 
were mainly focused on the prediction of the fraction absorbed, whereas metabolic capacity 
and disposition of the formed metabolites has not been reported. Nonetheless, indications 
exist that when only intestinal transport is measured, the metabolic extraction of the tissue 
might lead to false predictions of fraction absorbed [21]. 
 
In this study, we adapted the precision-cut slice method to human tissue previously 
developed for rat intestinal tissue to study drug metabolism. The viability of slices was 
evaluated by measuring intracellular ATP levels, morphology and metabolic stability during 4 
h of incubation. Slices of proximal jejunum and colon tissue were incubated with high 
concentrations of testosterone (TT) or 7-hydroxycoumarin (7HC) to assess phase I and 
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respectively phase II capacity at Vmax. Additionally, slices were incubated with a cocktail of 
CYP substrates (midazolam, coumarin, diclofenac and bufuralol) at concentrations below 
Km. These compounds are probes for CYP3A4/5, CYP2A6, CYP2C9 and CYP2D6. 
Secondly, from the same proximal jejunum tissue samples we prepared mucosal sheets for 
the Ussing chamber set-up. These sheets were incubated up to 4 h with the cocktail or with 
7HC, while the viability was monitored by electrical parameters [22]. This enabled a direct 
comparison between the metabolic activity of human intestinal tissue either mounted in 
Ussing chambers or in the form of precision-cut slices. 
 
 
Materials and Methods 
Chemicals 
Dimethylsulfoxide (DMSO), tri fluoro acetic acid (TFA), low gelling temperature agarose (type VII-A), 
amphotericin B solution (250 µg/ml), D-glucose, 7-hydroxycoumarin (7HC), 7-hydroxycoumarin-
glucuronide (7HC-GLUC), HEPES (N-(2-hydroxyethyl) piperazine-N’-(2-ethanesulfonic acid)), sodium 
bicarbonate, -glucuronidase, sulfatase, testosterone, 11-hydroxytestosterone (11-TOH), 6-TOH 
and bovine serum albumin were purchased from Sigma-Aldrich (St. Louis, MO). Williams Medium E with 
Glutamax-I (WME) and gentamicin (50 mg/ml) solution were obtained from Invitrogen (Paisley, UK). 
Formaldehyde solution (3.8%) was purchased from Mallinckrodt Baker B.V. (Deventer, The 
Netherlands). Hydroxy-bufuralol maleate salt, bufuralol hydrochloride salt, 1-hydroxy midazolam and 7-
hydroxycoumarin-sulphate (7HC-SULF) were purchased from Ultrafine (Manchester, UK). 4-Hydroxy-
diclofenac was obtained from Gentest (Woburn, USA). Midazolam was purchased from Lipomed AG 
(Arlesheim, Switzerland). Sodium azide was obtained from Kebo lab (Spånga, Sweden). Sodium 
chloride, EDTA (ethylene diamine tetra-acetic acid), formic acid, tris-HCl, dichloromethane and sodium 
acetate were obtained from Merck (Darmstadt, Germany). Acetonitril (ACN) and methanol (MeOH) were 
purchased from Rathburn (Walkerburn, Scotland). Ethanol was obtained from Kemetyl (Haninge, 
Sweden). 2-, 16-, 11-TOH were obtained from Steraloids (Newport, RI).  
Human tissue 
Human tissue originated from surgical resections with approval from the regional ethical committee in 
Gothenburg (Sweden) and from each of the individual patients; proximal jejunum was obtained from 
obesity patients from Sahlgren’s University hospital (Sweden) and the colon resections from patients 
suffering colon carcinomas from East Hospital (Gothenburg, Sweden). Donor characteristics are listed 
in Table I. After surgical removal, tissue was directly stored in ice-cold constantly oxygenated (with 
carbogen, 95% O2 and 5% CO2) Krebs-Bicarbonate Ringer (KBR) solution (pH 7.4) with the composition 
reported earlier [22].  
Preparation and incubation of human tissue 
Directly after tissue arrival in the laboratory, the tissue was put in fresh oxygenated ice-cold KBR 
solution and the muscle layers and serosa were carefully removed. In all cases, preparation of mucosal 
tissue was finished within 1-2 h calculated from excision. The end of mucosal preparation is referred to 
as t=0 in experiments.   
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Table I:  Donor Characteristics  
Proximal jejunum obtained from surgical resection from patients suffering obesity (a)
 
Number Age Gender Medication 
     1 46 W Unknown 
     2 (b) 42 W Unknown 
     3 (b)
 
49 M Lansoprazol 
     4 32 W Unknown 
     5 (b)
 
39 W Venlafaxine, Metoprolol 
     6 54 M Chlorpromazin, Metformine, Rosiglitazon 
     7 (b)
 
31 M Unknown 
Colon obtained from surgical resection from patients suffering colon carcinoma (a) 
Number Age Gender    Region                                Medication 
     8 68 W 
   Cecum                    Lactulose, Ferrous sulphate, 
                                                Paracetamol 
     9 77 W 
   Cecum                Furosemide, Potassium chloride, 
                                 Zopiclon, Bisoprolol, Oxazepam 
    10 56 M Sigmoideum                  Metoprolol, Lisinopril 
    11 59 M Sigmoideum                               non 
    12 79 W  Unknown                               Unknown 
a) Approval from regional ethical committee and individual patients was obtained for all investigations 
b) Donor tissue used for Ussing Chamber and precision-cut slice incubation 
Preparation of precision-cut slices 
Mucosal tissue was transferred to ice-cold oxygenated Krebs-Henseleit buffer (containing 10 mM 
HEPES and 25 mM D-glucose, pH 7.4). Tissue was cut in pieces of 7-9 mm width and variable length 
and was subsequently vertically embedded in 3% low-gelling temperature agarose in 0.9% NaCl 
solution (37
o
C) to ensure that every slice consisted of all cell layers present in the mucosa. Then, the 
agarose solution was allowed to gel, using a pre-cooled (0
o
C) tissue embedding unit (Alabama 
Research and Development, Munford, AL). After the agarose solution had gelled, precision-cut slices 
(thickness about 400 M) were cut using a Krumdieck tissue slicer as described previously [17]. 
Incubation of precision-cut slices 
Slices were incubated individually in 12-wells culture plates (Costar no 3512, Corning Incorporated, NY, 
USA) in 1.3 ml of Williams Medium E with Glutamax-I (WME), supplemented with D-glucose (final 
concentration 25 mM), gentamicin (final concentration 50 g/ml), amphotericin B (final concentration 2.5 
g/ml). The culture plates were placed in a pre-warmed cabinet (37
o
C) in plastic boxes. Slices were 
incubated under humidified carbogen (95% O2 / 5% CO2) and shaken using an orbital shaker at 
approximately 45 rpm.  
Preparation and incubation for Ussing chambers 
Mucosal tissue was mounted onto the Ussing chamber segment holder as flat sheets with a surface 
area of 1 cm
2
. Each of the two chamber compartments on both sides of the segment was subsequently 
filled with 10 ml oxygenated KBR (room temperature) continuously gassed with carbogen (95% O2 / 5% 
CO2), stirred with approximately 300 rpm and slowly warmed until 37
o
C by water jackets. The tissue 
was mounted and placed in the Ussing chamber set-up after which the tissue was allowed to stabilize 
for 30 minutes to recover from the preparation and to equilibrate in the chambers.  
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Viability testing of precision-cut slices 
Morphology: The condition of precision-cut slices was evaluated after 4 h of incubation by morphology. 
After incubation in triplicate per experiment, slices were stored in 3.8% formaldehyde solution at 4
o
C. In 
addition, directly after tissue arrival in the laboratory, a piece of tissue was put in ice-cold 3.8% 
formaldehyde solution as a control. Samples were sent to HistoCenter AB (Box 138, 421 22 V. 
Frölunda, Sweden) for further processing and haematoxylin and eosin staining. Colon slice incubations 
for morphology were performed in two experiments with tissue from two subjects in triplicate; small 
intestinal slice incubations were performed in 5 experiments with tissue from five subjects in triplicate.  
 
Intracellular ATP levels: Intracellular ATP levels were evaluated to judge the overall metabolic 
condition of the tissue after 4 h of incubation. Directly after tissue preparation, 3 pieces of tissue were 
snap-frozen as controls. Intracellular ATP levels were determined according to the method described by 
de Kanter et al. [23]. Directly after incubation, slices were put in 1 ml ice-cold 70% ethanol containing 2 
mM EDTA (pH 10.9) to precipitate the proteins, and directly snap-frozen in N2(l) and stored at –80
o
C 
until further use. Subsequently, samples were thawn on ice and homogenized by sonication. Samples 
were centrifuged (3 min, 4
o
C, 10,000 g) to spin down the proteins, after which the supernatant was 
transferred to a new cup and the pellet was used for protein determination. The supernatant was diluted 
with 100 mM Tris-HCl, 2 mM EDTA solution (pH 7.8) and analyzed using the ATP Bioluminescence 
Assay Kit CLS II (Roche Applied Sciences, Mannheim, Germany) measuring luminescence using a 
plate reader (Spectramax microplate reader, Molecular devices, Sunnyvale, California). ATP was 
determined in four experiments using tissue from four different donors in triplicate. 
 
Stability of drug metabolism rate: The stability of metabolic rate was determined between 0 h and 4 h 
of incubation. To evaluate phase I metabolism, slices were incubated with TT (final concentration 250 
M, 1% MeOH) or a cocktail of 4 compounds: midazolam (3 M), diclofenac (5 M), bufuralol (10 M) 
and coumarin (3 M) with 0.35% MeOH as a final solvent concentration. As control, medium was 
incubated with substrate but without slice. After 1, 2, 3 and 4 h of incubation with testosterone, slice and 
medium were harvested together and stored at –20
o
C until further use. In earlier rat studies, we found 
that significant amounts of testosterone metabolites were retained within the slice [17]. Therefore, slice 
and medium were analyzed together. 
For cocktail incubations, no metabolic interactions were detected between substrates and these 
concentrations (T. Andersson, AstraZeneca, Mölndal (personal communication)). Further, pilot 
experiments showed that only minor amounts of the cocktail metabolites were retained in the slice that 
were barely detectable. Therefore, only the medium samples were analyzed. During 0-4 h of incubation, 
medium samples (100 l) were taken every hour. The last sample contained slice tissue and remaining 
medium. Samples were stored at -20
o
C until further use. 
To evaluate phase II metabolism, slices were incubated with 7HC (500 M, 1% MeOH) and as a 
control, medium was incubated with substrate. Medium samples (200 l) were taken every hour 
between 0 h and 4 h and stored at –20
o
C. After incubation, slices were stored at –20
o
C for protein 
determination.  
Metabolism experiments with proximal jejunum were performed on tissues from 5-8 donors in triplicate. 
Metabolism experiments in colon were performed on tissue from 5 donors in triplicate. 
Viability testing Ussing chamber preparations 
Electrical parameters: Viability was monitored by measuring electrical parameters as described before 
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[22]: the Potential Difference (PD) is reflecting the voltage gradient generated by the tissue, the short-
circuit current (SCC) is reflecting the ionic fluxes across the epithelium and the resistance (R) is 
reflecting tissue integrity.  
In brief, a four electrodes system recorded electrical parameters during the experiment. The Potential 
Difference (PD) was recorded using calomel electrodes connected by agar/NaCl-bridges. Every 5 
minutes, 5 current (I) pulses (0  15,  30 A) were sent via AgCl electrodes through the chamber after 
which the voltage response (U) was measured. The current (I) - voltage (U) pairs form a linear plot from 
which the PD can be deduced. PD was obtained from the intersection with the voltage axes, when I=0, 
the resistance (R) of the tissue segment was the slope of this plot. R was corrected for external, non-
tissue resistance by the recorder system. The short-circuit current (SCC) was calculated from Ohm’s 
law: I = U/R. 
 
Stability of drug metabolism rate: Tissue from four individual donors was used to prepare both 
precision-cut slices and Ussing chamber preparations to enable a direct comparison between the 
metabolic activity in the Ussing chamber preparations and precision-cut slices. In table I it is indicated 
which tissue was used for both experiments.  
For a set of 8 chambers per subject and per day, two experimental set-ups were chosen: I) Four 
chambers were incubated with the cocktail of the four CYP substrates: midazolam (3 M), diclofenac (5 
M), bufuralol (10 M) and coumarin (3 M). II) Four chambers were incubated with 7HC (500 M, 1% 
MeOH) to assess phase II metabolism. The metabolic reactions were monitored during 4 hours of 
incubation. At 1, 2, 3 and 4 h of incubation with the model substrates from one of the chambers, tissue 
and medium (both apical (A) and basolateral (B) individually) were harvested. This terminated the 
incubation of one chamber at that specific time point. Samples were stored at 4
o
C until the end of the 
experiment and subsequently stored at –20
o
C until further use.  
Metabolite analyses 
Testosterone sample analysis: After thawing (at 4
o
C), samples were homogenized using a sonicator. 
Then, 10 ml 11-TOH (internal standard, 0.2 mg/ml) and 6 ml dichloromethane were added. The total 
mixture was vortexed and centrifuged using a Beckman-Coulter CS-6KR centrifuge (Beckman Coulter, 
Fullerton, CA) (10 min, 4
o
C, at 800 g). The water layer was removed and the dichloromethane 
evaporated overnight. The residue was dissolved in 130 l of 50% MeOH and then analyzed by HPLC 
as described previously [24]. The concentration range of the standard curve was 2-10 M. The LLOQ 
(Lower Limit of Quantitation) was 0.1 M. The intraday and interday variability (2 M) were resp. 6.1 
and 8.8 %CV (coefficient of variation).  
 
Cocktail sample analysis: Slice samples containing medium and tissue were homogenized by 
sonication. Ussing chamber tissue samples were homogenised in 2 ml fresh WME using a potter 
Elvehjem. Subsequently, two volumes of ACN were added to precipitate the proteins. Then, samples 
were centrifuged (10 min, 20
o
C, 4000 g). The supernatant, used for metabolite analysis, was diluted 
with 2 volumes of water (final concentration of ACN: 30%). The precipitate was stored at –20
o
C for 
protein determination. Medium samples were directly pipetted into a 96-wells plate together with 
standards (1’OH-midazolam, 4’OH-diclofenac, OH-bufuralol and 7’OH-coumarin) dissolved in both 
water and 30% ACN. The plate was centrifuged for 20 min (4000 g, 4
o
C) before injection into a LC-MS 
occurred. For OH-bufuralol, the concentration range of the standard curve used was 0.05-0.25 M and 
the interday variability (0.25 µM) was 5.6% CV. For 4’OH-diclofenac and 1’OH-midazolam the 
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concentration range of the standard curves was 0.25-1 µM and the interday variability (1 µM) was resp. 
3.4 and 1.3% CV. The LLOQ was lower than 5 nM for OH-bufuralol, 1’OH-midazolam and 4’OH-
diclofenac.  
LC separations were performed on a reversed-phase HyPURITY C18 analytical column (50 mm x 2.1 
mm i.d., 5 m, ThermoQuest, Runcorn, UK) with a HyPURITY C18 guard column (2.1 x 10 mm, 5 m) at 
40°C. The mobile phase consisted of a mixture of (A) 0.1% formic acid in water and (B) 0.1% formic 
acid in ACN. A gradient elution containing solvents A and B was performed: solvent A was linearly 
decreased from 95% to 20% during 3 min, where it remained isocratic for 0.2 min. Then A was 
increased to 95% during 0.1 min and re-equilibrated at 95% A for 2.5 min. A flow-rate of 0.75 ml/min 
was used and an aliquot of 15 l was injected for analysis. The mass spectrometric analyses were 
performed with a triple quadrupole mass spectrometer, API4000, equipped with electro spray interface 
(Applied Biosystems/MDS Sciex, Concord, Canada). The instrument settings were optimized using the 
individual analytes. The MRM transitions of the precursor ions to the corresponding product ions were 
monitored for the analytes. Instrument control, data acquisition and data evaluation were performed 
using Applied Biosystems/MDS Sciex Analyst 1.4 software. 
 
Deconjugation of cocktail samples: To test whether further conjugation of the hydroxy-metabolites of 
the cocktail compounds had occurred, Ussing chamber medium samples after 2 h of incubation were 
deconjugated. For this, 40 l medium was added to 65 l 1 N sodium acetate buffer (pH 4.5) containing 
5480 U/ml -glucuronidase and 59 U/ml sulfatase and incubated for 2 h at 37C. The reaction was 
terminated by precipitation of the proteins adding 2 volumes of ACN. After vortexing, the samples were 
centrifuged and diluted twice with water, before analysis. Analysis occurred as described in the section 
cocktail sample analysis.  
 
7HC sample analysis: After thawing, sodium azide (final concentration 0.1 mg/ml) was added to the 
samples to prevent bacterial growth. Subsequently, the samples were centrifuged (3 min, 4 
o
C, 10,000 
g) and metabolites were determined by HPLC. 7HC, 7HC-GLUC and 7HC-SULF were used as 
references. Chromatography was performed on a Zorbax Column SB-C18 (4.6 mm x 15 cm, 5m, 
Hewlett Packard (ChromTech AB, Hägersten, Sweden). The mobile phase consisted of A) 0.1% TFA 
and B) 0.1% TFA in 100% ACN. The separation run lasted 16.0 minutes, including column equilibration. 
The gradient was as follows: 0% B for 1 min, followed by linear increase to 20% B over 4 min, followed 
by a step gradient to 85% B for 6 min, remained at 85% B for 3.5 min and returned to 0% B for 1.5 min. 
Per sample, 50 l was injected and the flow rate was 0.8 ml/min. The concentration range of the 
standard curves of 7HC-GLUC and 7HC-SULF was 0.25-1 µM and the interday variability (1 M) was 
resp. 0.5 and 3.4% CV. The LLOQ was lower than 0.25 M.  
Protein determination 
Since slices had somewhat different sizes, the protein content was determined on all slice samples after 
ATP analysis, 7HC incubations or cocktail incubations to enable expression on protein basis. Protein 
values were determined on all Ussing chamber tissue samples as well. After incubation samples were 
stored at –20C until further use. Subsequently, samples were thawn and 5 N NaOH was added: 20 l 5 
N NaOH for slice samples used for ATP determination and 7HC metabolism in eppendorf cups and 200 
l 5 N NaOH for cocktail slice samples and Ussing chamber tissue samples in centrifuge tubes. Forty 
min of incubation at 37C followed to dissolve the tissue. Then, water was added to obtain a final 
concentration of 0.1 N NaOH needed for the analysis. Tissue was homogenized using sonication and 
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further diluted to determine the protein content using Bio-Rad protein assay dye reagent (Bio-Rad, 
Munich, Germany) with bovine serum albumin as standard. For testosterone experiments, the protein 
content could not be determined, since the proteins were removed together with the water layer during 
extraction. Therefore, the average of the protein values of 7HC incubations was used. Per experiment, 
79-97% of the slices had a protein content ranging from 50% to 150% of the average protein content. 
Statistics 
Statistical significance of the difference between Ussing chamber preparations and precision-cut slices 
was determined using a paired Student´s t -test. The linearity of metabolic rates in time was determined 




Viability assessment of small intestinal and colon slices 
Three different parameters were assessed to evaluate the viability of small intestinal and 
colon slices after 4 h of incubation: morphology, ATP levels and metabolic stability. Small 
pieces of non-incubated tissue served as controls for morphology and ATP levels. 
 
Morphology: Although the villi showed somewhat flattening, the overall tissue morphology 
and the morphological appearance of the colonocytes/ enterocytes of colon and proximal 
jejunal slices remained intact during 4 h of incubation in comparison with non-incubated 
control tissue. No cell swelling or necrosis was observed. The morphological evaluation 
indicated that the number of intact epithelial cells was not reduced during this incubation 




Figure 1: Micrographs of small intestinal tissue as 
control (A) and slices after 4 h of incubation (B). In 
addition, micrographs of colon tissue as control (C) 
and colon slices after 4 h of incubation (D). 
Staining: Haematoxylin and eosin (100x for small 
intestine; 200x for colon). Representative 
micrographs from 5 experiments (small intestine) 




Intracellular ATP: General viability of small intestinal slices was assessed in four 
experiments by measurement of intracellular ATP levels. The level of ATP in tissue pieces 
harvested directly after preparation of the mucosal sheets was 1.2 nmol/mg protein and 






Viability in Ussing chamber preparations 
Electrical parameters: To evaluate the tissue integrity of Ussing chamber preparations, 
electrical parameters were monitored. In figure 2, the electrical parameters of Ussing 
chamber preparations are shown during 4 h of incubation with substrates. The potential 
difference (PD), reflecting the voltage gradient 
generated by the tissue, was 7.9 mV and 
decreased significantly (p < 0.003) to 4.5 mV after 
4 h of incubation. The short-circuit current values 
(reflecting the ionic fluxes across the epithelium) 
were 2 A/mm
2
 at the beginning of the experiment 
and after a small increase to 2.3 A/mm
2
 
decreased non-significantly to 1.2 A/mm
2
 after 4 
h of incubation. The resistance (R), reflecting 
tissue integrity, increased non-significantly from 42 
to 48 Ohm x cm
2





Figure 2: Electrical parameters of human intestinal 
segments in the Ussing chamber technique during 4 h of 
incubation: potential difference (PD) (A), short-circuit 
current (SCC) (B) and resistance (R) (C). Results show 
mean  SEM of 4 donors; each time point represents 6-
32 chambers.  
 
 
Figure 3: Metabolic activities as detected in precision-cut slices toward testosterone prepared from 
small intestine: (A) Androstenedione and (B) 6-TOH, 16-TOH and 2-TOH. Results show mean  
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Stability of metabolic rate in precision-cut slices 
Testosterone metabolism 
The rates of testosterone metabolite formation in human proximal jejunum are shown in 
figure 3. Four different metabolites could be quantified: androstenedione, 16-, 6- and 2-
hydroxytestosterone. Androstenedione and 16-TOH were formed at a constant rate up to 4 
h of incubation (R
2
 > 0.93). For 6- and 2-TOH the highest formation rate was detected 
between 0 and 1 h of incubation. In order from highest to lowest formation rate: 
androstenedione (316 pmol/min/mg protein), followed by 6-TOH (107 pmol/min/mg protein 
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Figure 4: Metabolic activities detected using 
precision-cut slices and Ussing chamber 
preparations prepared from proximal jejunum. Phase 
I reaction rates were assessed with a cocktail of 4 
compounds: midazolam towards 1’OH-midazolam 
(A), diclofenac towards 4’OH-diclofenac (B), 
bufuralol towards OH-bufuralol (C) and coumarin 
towards 7’OH-coumarin (not detectable). Phase II 
reactions were monitored using 7HC towards 7HC-
glucuronidation (D) and 7HC-sulphation (E). Results 
are mean  SEM of 4 donors; in each experiment 3 
slices and 1 Ussing chamber preparation were 




Hydroxylation of midazolam, diclofenac, bufuralol and coumarin 
Slices were incubated with a cocktail of drugs (midazolam, diclofenac, bufuralol and 
coumarin) to further evaluate the stability of CYP mediated reactions. The metabolite 
formation in time is depicted in figure 4A-C. No 7’OH-coumarin metabolite formation could 
be detected in the slices. 1’OH-midazolam (R
2
 > 0.92), 4’OH-diclofenac (R
2 
> 0.97) and OH-
bufuralol (R
2 
> 0.93) formation were time-dependent up to 4 h of incubation. The fastest 
metabolic hydroxylation rate was detected using midazolam as a substrate (11.6 
pmol/min/mg protein), followed by diclofenac (7.7 pmol/min/mg protein) and bufuralol (1.3 
pmol/min/mg protein). In figure 4, the metabolite values in the slices are depicted as mean 
values of 4 experiments using tissue from 4 different donors. These were performed 
simultaneously with Ussing chamber experiments. Two additional slice experiments were 
performed with the cocktail. The obtained results were in line with the results depicted in 
figure 4 (data not shown). The range of metabolite formation rates in slices in the 6 
experiments were 8.3 - 17 pmol/min/mg protein (1’OH-midazolam), 4.4 – 9.4 pmol/min/mg 
protein (4’OH-diclofenac) and 0.2 – 2.2 pmol/min/mg protein (OH-bufuralol).  
In colon slices, the hydroxy-metabolite formation for all substrates was below the detection 
limit.   
 
7HC conjugation 
Figure 5 shows that for both glucuronidation and sulphation the metabolic rates were 
constant during the first 4 h of incubation in both small intestine (open symbols, R
2
 > 0.98) 
and colon (closed symbols, R
2
 > 0.98).  
In small intestinal as well as in colon slices, the glucuronidation rate is higher than the 
sulphation rate. Comparing colon and small intestinal slices, comparable rates were found 
for both glucuronidation (small intestine: 315 pmol/min/mg protein, colon: 377 pmol/min/mg 






Figure 5: Conjugation activity toward 7HC 
was measured using precision-cut slices 
prepared from small intestine (open marks) 
and colon (closed marks). 7HC-
glucuronide () and 7HC-sulphate 
formation () were measured during 0-4 h 
of incubation.  Results are mean  SEM of 
5-7 donors; in each experiment 3 slices 
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Stability of metabolic rate in Ussing chamber preparations 
Hydroxylation of midazolam, diclofenac, bufuralol and coumarin 
In the Ussing chamber incubations, metabolites which were detected in the apical chamber 
(A), basolateral chamber (B) and in the tissue (T) are indicated in figure 6. The sums of the 
metabolites in these three compartments correspond to the total metabolite formation in the 
Ussing chamber incubations and are depicted in figure 4A-E. 
Figure 6: Distribution of formed metabolites over the apical (A), basolateral (B) and tissue (T) 
compartment was measured using human proximal jejunum in the Ussing chamber set-up. Phase I 
reaction rates were assessed with a cocktail of 4 compounds, formation of 1’OH-midazolam (6A), 4’OH-
diclofenac (6B), OH-bufuralol (6C) and 7’OH-coumarin (not detectable). Phase II reactions were 
monitored using 7HC towards 7HC-glucuronide (6D) and 7HC-sulphate (6E). Results are mean  SEM 
of 4 donors; in each experiment 1 Ussing chamber preparation was incubated per time point. 
Figure 6
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Like in the slices, 7’OH coumarin could not be detected in Ussing chamber experiments 
after 4 h of incubation neither in compartment A nor B. However, low amounts of the 
metabolite could be detected in tissue, indicating a low activity of the CYP2A6 enzyme.  
1’OH-midazolam (R
2
 > 0.95) formation and 4’OH-diclofenac (R
2
 > 0.99) formation were 
linear up to 3 h and OH-bufuralol formation up to 4 h of incubation (R
2
 > 0.98) (figure 4A-C). 
As for slices, the highest metabolite formation was 1’OH-midazolam (9.3 pmol/min/mg 
protein), followed by 4’OH-diclofenac (6.9 pmol/min/mg protein) and OH-bufuralol (1.3 
pmol/min/mg protein). All detectable hydroxy-metabolites were excreted in a higher extent 
into the apical compartment compared to the basolateral compartment (significant for 1’OH-
midazolam (p < 0.005) and 4’ OH-diclofenac (p < 0.007), but not significant for OH-bufuralol 
(p < 0.11) (figure 6A-C).   
The total amount of metabolites that accumulated in the tissue remained constant during 
incubation: after 1 h of incubation 22-34% of the formed metabolites were retained within the 
tissue and after 4 h of incubation 10-13%.   
De-conjugation of cocktail metabolites 
To evaluate possible conjugation of the hydroxy-metabolites formed, media of Ussing 
chamber preparations (after 2 h of incubation) from both A and B compartments were de-
conjugated and re-analyzed (table II). In the A as well as the B compartment no relevant 
conjugation could be detected for 1’OH-midazolam, OH-bufuralol or 7’OH-coumarin 
(remained below the detection limit). However, the amount of 4’OH-diclofenac increased to 
133% in A and to 249% in B after deconjugation, resulting in an increase in total metabolism 
of 145%.  
Table II: % increase in metabolite concentration after incubation with deconjugating enzymes. 
Deconjugated samples were Ussing chamber medium samples incubated with cocktail of compounds 
for 2 h (n=4, mean  SEM)  
 Apical chamber                          
Basolateral chamber 
Basolateral chamber                           
1’OH-midazolam 108   6.8 % 110  4.6 % 
4’OH-diclofenac 133  11.6 % 249  30.8 % 
OH-bufuralol 108  4.8 % 92  8 % 
7HC conjugation 
For 7HC, tissue glucuronidation and sulphation rates were constant during 4 h of incubation 
in the Ussing chambers (R
2 
> 0.95) (figure 4D and E). As for slices, glucuronidation (415 
pmol/min/mg protein) occurred faster than sulphation (66 pmol/min/mg protein). The 
excretion of both conjugates to the A and B compartments differed for the two conjugates. 
For 7HC-GLUC, a slightly higher excretion to B than to A was observed (non-significant: p > 
0.08) (figure 6D). For 7HC-SULF, more metabolite (although non-significant: p < 0.08) was 
excreted towards A compared to B (figure 6E). After 1 h of incubation, 18% of 7HC-GLUC 
and 0% 7HC-SULF are retained within the tissue.  However, after 4 h of incubation the total 
amount retained in the tissue was low in relation to the amount excreted (0% for 7HC-SULF, 
2.5% for 7HC-GLUC).  
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Comparison of metabolic rates in precision-cut slices and Ussing chamber 
preparations  
Proximal jejunum tissue used in the Ussing chamber incubations as well as precision-cut 
slices were prepared at the same time from tissues of four donors. For 1’OH-midazolam 
formation, slices had a slightly, but significantly higher metabolic rate (p < 0.03 tested with a 
paired 2-tailed student’s t -test) compared with Ussing chamber incubations (figure 4A). For 
4’OH-diclofenac and OH-bufuralol formation (figure 4B and C), the metabolic rates were 
similar for precision-cut slices and Ussing chamber preparations.  
For 7HC conjugation (figure 4D and 4E), the metabolic rates in Ussing chamber 
preparations were slightly, but significantly higher (p < 0.02 tested with a paired 2-tailed 




Recently, rat intestinal precision-cut slices were presented as a tool to study intestinal 
metabolism [17,18,25]. In addition, the rat and human intestinal Ussing chamber technique 
has been optimized as a tool to predict the absorption of the original compound [21] and not 
for metabolism. Since predictive in vitro methods are of high importance to investigate 
human intestinal drug metabolism, we characterized the viability and metabolic activity of 
human intestinal slices and compared it with the metabolic activity in Ussing chamber 
preparations. 
 
In slices, the intracellular ATP levels and morphology indicated that they were viable up to 4 
h of incubation. The increase of intracellular ATP levels during 4 h of incubation can be 
explained by the temperature change from 4C (storage) to 37C during incubation, allowing 
ATP levels to be re-established. This result is in line with earlier observations obtained with 
human liver, lung and kidney slices [23]. In Ussing chamber preparations, the electrical 
parameters indicate that the viability and integrity were maintained for at least 4 h, since the 
tight-junctions (reflected by the resistance) remained intact, which is a high-energy process. 
However, a small decrease of ion transport activity (PD and SCC) occurred, which is 
probably due to some loss of cells and surface area, as has been described by Polentarutti 
et al. [22].  
The metabolic stability was our major focus during these studies. Therefore, proximal jejunal 
slices were incubated with TT to test phase I activity. Formation rates of 6-TOH and 2-
TOH, both mediated by CYP3A4 [26], tended to decline after 1 h. In contrast, 
androstenedione formation (mediated by 17-HSD [27] and CYP2C19 [26]) and 16-TOH 
formation were constant up to 4 h. This may indicate different half-lives of the individual 
(iso)enzymes [28] or product inhibition. 
The decision to use a cocktail of model substrates was made to increase the amount of 
information that could be obtained per donor tissue: Midazolam 1’hydroxylation 
(CYP3A4/3A5), diclofenac 4’hydroxylation (CYP2C9), coumarin 7’hydroxylation (CYP2A6) 
and bufuralol hydroxylation (CYP2D6) were chosen based on substrate specificity [29]. Slice 
formation rates of 4’OH-diclofenac, 1’OH-midazolam, OH-bufuralol, 7HC-GLUC and 7HC-
SULF were constant up to 4 h of incubation. The difference in the stability of 1’OH-
midazolam (non-saturated conditions) and 2-TOH and 6-TOH formation (saturated 
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conditions) could be explained by the exhaustion of co-factors and/or product inhibition of 
2-TOH and 6-TOH. 
Only for 7HC-GLUC formation a lag-phase was observed. Pre-incubation of slices for 1 h did 
not influence this lag-phase (pilot experiment, data not shown). No lag-phase was observed 
in Ussing chamber experiments with 7HC, since both medium and tissue were harvested. In 
these tissues a constant amount of metabolite was detected up to 4 h of incubation, 
indicating that accumulation of the metabolites in slices may explain the lag-phase. 
Therefore, metabolic rates used for comparison are expressed as metabolite formation 
measured between 1 and 4 h of incubation. 
Hydroxylation of cocktail compounds in colon was undetectable and thus much slower 
compared with proximal jejunum. For 7HC-sulphation and 7HC-glucuronidation, the 
metabolic rates expressed per mg protein were similar in colon and proximal jejunum as was 
also found in rat [18]. In previous rat studies, intestinal slice incubations with 7HC showed 
higher glucuronidation rates (750 (colon) and 977 pmol/min/mg protein (proximal jejunum)) 
compared to human slices (377 and respectively 315 pmol/min/mg protein). The 
glucuronidation/sulphation ratio was higher in rat (colon: 16 and proximal jejunum: 23) than 
in human (colon and proximal jejunum: 6) [18], suggesting a clear species difference. This is 
in contrast with liver in which the glucuronidation/sulphation ratio is higher in human (19) 
than in rat (15) [23]. However, in future studies the test group should be expanded and also 
intestinal tissue from healthy subjects should be taken into account, to proof the existence of 
this species difference. To our knowledge, it is unknown whether obesity influences drug 
metabolism in the small intestine.  
When Ussing chamber preparations were incubated with the cocktail of CYP substrates or 
7HC, the metabolite formation was linear up to 3-4 h of incubation. The distribution of 
metabolites in the A and B compartments, however, differed clearly per substrate. This may 
indicate a clear role of transporters. Possibly, metabolites appear at the apical site due to 
metabolism in slought-off cells. To exclude this, we sampled medium after incubation and 
incubated these for another 3 h. No further metabolism was detected in these incubations 
confirming that the formation of the metabolites occurred in cells within the tissue and was 
then excreted into the apical compartment.  
The role of transporters in uptake and excretion of compounds in the intestine has been 
extensively discussed [11,30]. The co-localization of CYP3A4 and Pgp in the villi tips of 
human intestine has also been reported [31] indicating a collaborative role between 
enzymes and efflux transporters in the gut. In Ussing chamber studies using pig intestine, 
extensive luminal efflux of the oxidative product hydroxy-sirolimus was reported [32]. For 
glucuronide and sulfate conjugates formed in rat enterocytes, a significant extrusion into the 
intestinal lumen has been reported as well [33]. Apical excretion was shown to be facilitated 
by MRP2 in Caco-2 cells [10], which is in line with localization of MRP2 at the apical 
membranes of enterocytes [34]. The present study showed for the first time a clear luminal 
efflux of hydroxy-metabolites in human intestine. Elucidation of the identity of the 
transporters involved in the apical and basolateral excretion of the metabolites will be the 
focus of further research. 
 
A direct comparison of metabolic activity between the methods could be made, since tissues 
from the same donors were used to prepare both slices and Ussing chamber preparations. 
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The two techniques offer different advantages and limitations. The slice technique requires 
only 4 mg of tissue per slice and is technically easier to use. So, much more experimental 
variations may be tested within one experiment. More intestinal tissue is needed to mount 
tissue in the Ussing chamber set-up (around 160 mg mucosal tissue per set-up). However, 
the latter has the major advantage that vectorial transport of drugs and metabolites can be 
studied. The incubation conditions for both systems were also slightly different. In fact, these 
were chosen on the basis of optimized conditions developed for the two systems separately. 
Surprisingly, in spite of these differences similar metabolic activities were found for all 
reactions (phase I and II) tested.  
 
After intensive literature search, we feel that we are unable to compare the obtained results 
with earlier published microsomal data, since no exact scaling factor is known. Although 
certain reports give the microsomal protein yield after isolation, the loss during isolation has 
not yet been reported. Furthermore, for intestinal preparations, the origin of the tissue 
(location along the tract, patients/donor background) and/or the storage and preparation 
techniques used, will anyhow introduce differences in the metabolic rates. Only when 
studies are performed with the same donor material, metabolic rates of different methods 
can be compared. This might be a subject for future studies.  
 
To underline the intrinsic importance of the enterocytes in drug metabolism, we compared 
the intestinal metabolic rates with activities obtained using human liver. First of all, a 
remarkably low interindividual variation was seen in this study using gut tissues. For 
testosterone hydroxylation only a 2-fold difference was detected between six donors. This is 
not in line with the observation of others that intestinal metabolism is highly variable [35], but 
may be related to the relatively small number of obese donors used in our study. Liver slice 
values of human TT hydroxylation have been reported to be: 65 (6-TOH), 24 (2-TOH), 
223 (androstenedione) and 5 (16-TOH) pmol/min/mg protein [23]. The proximal jejunum 
rates detected in the present study were resp. 1.6, 1, 1.4 and 1.8 times higher compared 
with the liver activity. However, these activities cannot be directly ascribed to the activity of 
liver hepatocytes and intestinal enterocytes. In liver, hepatocytes represent more than 80% 
of wet weight of which about 50% is contributing to the metabolic activity in slices of 250 m 
thickness [36], indicating that hepatocyte activity is 2.5 times the tissue value. In intestinal 
mucosa, enterocytes account for approximately 25% of total wet weight (morphological 
observation), indicating that the enterocyte activity is 4 times the tissue value. From these 
observation, we come to the remarkable conclusion that the phase I metabolic rate in 
enterocytes is estimated to be 1.7 to 2.9 times higher than that in hepatocytes.  
7HC-glucuronidation and 7HC-sulphation rates in human liver slices have been reported to 
amount 880 and 33 pmol/min/mg protein for 7HC-GLUC and 7HC-SULF respectively [37]. If 
the above mentioned assumptions are taken into account, glucuronidation rates in 
enterocytes in the present study reach 60-70% of the hepatocyte values. Enterocyte 
sulphation rates are approximately 250-300% of the sulphation rate in hepatocytes. We 
conclude that sulphation rates in enterocytes of proximal jejunum as well as colon are higher 




From the present study it can be concluded that both precision-cut intestinal slices as well 
as Ussing chamber preparations are valuable tools to study human intestinal drug 
metabolism. Both systems remain viable up to 4 h and exhibit drug metabolism at similar 
rates. Interestingly, we estimate that human enterocytes exhibit at least comparable to even 
higher metabolic rates in comparison with hepatocytes. 
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